Studies of the Clinical Pharmacology and Therapeutic Efficacy of Pentoxifylline in Peripheral Obstructive Arterial Disease

Di Perri, Tullio; Carandente, Orazio; Vittoria, Aurelio; Guerrini, Maurizio; Messa, Gian Luca
July 1984
Angiology;Jul1984, Vol. 35 Issue 7, p427
Academic Journal
Studies were carried out to investigate the effects of pentoxifylline on various hemorheological (whole blood, plasma and serum viscosity, erythrocyte filtrability, hematocrit), hemostasiological (blood coagulation and fibrinolysis: euglobulin lysis time, fibrinogen, plasminogen, alpha-2-macroglobulin, alpha-l-antitrypsin, antiplasmin; platelet function: β-thromboglobulin), and hemodynamic factors (limb perfusion: rest and peak flow, time to peak flow; systemic blood pressure, heart rate). In addition, clinical efficacy was monitored in claudicants by assessing walking capacity under placebo controlled double blind cross over conditions. The investigations disclosed the positive influence of acute and chronic pentoxifylline administration on hemorheological, hemostasiological and perfusion parameters, most of the changes recorded being statistically significant. The clinical benefit of pentoxifylline (Trental 400) treatment was demonstrated by the significantly superior increase in walking capacity in comparison to placebo in the controlled study.


Related Articles

  • Tissue Factor Pathway Inhibitor Is a Potent Inhibitor of Plasmin. Klauser, Rainer J.; Hoppensteadt, Debra; Fareed Jawed // Clinical & Applied Thrombosis/Hemostasis;Apr1998, Vol. 4 Issue 2, p114 

    Recombinant tissue factor pathway inhibitor (TFPI) was found to be a potent inhibitor of plasmin. In an amidolytic assay the inhibition constant K, was found to be 2.86 x 108 M. TFPI in the same concentration range also inhibited the activation of plasminogen by tissue plasminogen activator...

  • Plasma Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Primary and Secondary Thrombocytosis. Kaftan, O.; Balcik, O. S.; Cipil, H.; Ozet, G.; Bavbek, N.; Koşsar, A.; Dagdas, S. // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p449 

    An elevated platelet count is a common finding in both hospitalized and ambulatory patients. Thrombosis and bleeding complications are more frequently observed in patients with clonal thrombocytosis than secondary thrombocytosis. The aim of this study was to investigate the behaviors of...

  • Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator. Mayfrank, L.; Kim, Y.; Kissler, J.; Delsing, P.; Gilsbach, J. M.; Schröder, J. M.; Weis, J. // Acta Neuropathologica;Nov2000, Vol. 100 Issue 5, p561 

    Intraventricular haemorrhage (IVH) occurs in up to 50% of patients with primary intracerebral haemorrhage and aneurysmal subarachnoid haemorrhage. It is a significant and independent contributor to mortality and morbidity in these intracranial haemorrhages. Using a model of isolated IVH, we...

  • Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Mauri, Tommaso; Bellani, Giacomo; Patroniti, Nicolo'; Coppadoro, Andrea; Peri, Giuseppe; Cuccovillo, Ivan; Cugno, Massimo; Iapichino, Gaetano; Gattinoni, Luciano; Pesenti, Antonio; Mantovani, Alberto // Intensive Care Medicine;Apr2010, Vol. 36 Issue 4, p621 

    Pentraxin 3 (PTX3) is an inflammatory mediator produced by neutrophils, macrophages, myeloid dendritic and endothelial cells. During sepsis a massive inflammatory activation and coagulation/fibrinolysis dysfunction occur. PTX3, as a mediator of inflammation, may represent an early marker of...

  • Utility of Clot Formation and Lysis Assay to Monitor Global Coagulation State of Patients with Severe Acute Pancreatitis. Zhu, Rongtao; Wei, Sidong; Wu, Chuanxin; Li, Shengwei; Gong, Jianping // Digestive Diseases & Sciences;May2012, Vol. 57 Issue 5, p1399 

    Background: Systemic inflammation affects hemostasis during severe acute pancreatitis (SAP). A hypercoagulable state occurs more frequently in SAP, which is not fully detected by traditional coagulation testing. Aims: The aim of this study was to evaluate the contribution of clot formation and...

  • Assays of different aspects of haemostasis -- what do they measure? Tynngård, Nahreen; Lindahl, Tomas L.; Ramström, Sofia // Thrombosis Journal;2015, Vol. 13 Issue 1, p1 

    Haemostasis is a complex process affected by many factors including both cellular and plasma components. It is a multistep process starting with platelet adhesion to damaged endothelium and ending in clot fibrinolysis. There are several methods available to study different aspects of haemostasis...

  • Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients. Fogari, Roberto; Preti, Paola; Lazzari, Pierangelo; Corradi, Luca; Zoppi, Annalisa; Fogari, Elena; Mugellini, Amedeo // European Journal of Clinical Pharmacology;Aug2003, Vol. 59 Issue 4, p271 

    Objective. The aim of this study was to compare the effects of benazepril and amlodipine in monotherapy versus in combination with plasma t-PA and PAI-1 activity in hypertensive type-2 diabetic patients. Methods. After an initial 6-week wash-out, single-blind placebo period, 38 patients, 17 men...

  • Effect of synthetic humic acid-multimetal complex on human plasma prothrombin time. Lu, F.; Huang, T.; Lee, J. // Bulletin of Environmental Contamination & Toxicology;Oct1994, Vol. 53 Issue 4, p577 

    The article offers a study on the prothrombin time of human plasma exposed to humic acid (HA)-MultiMetal complex. It says that the synthetic HA-MultiMetal complex can short human plasma prothrombin time, and HA enhances blood coagulation and prevent fibrinolysis. It also proposes that HA-metal...

  • Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause. Gebhart, J.; Laczkovics, C.; Posch, F.; Ay, C.; Reitter-Pfoertner, S.; Haslacher, H.; Muszbek, L.; Wolberg, A.; Pabinger, I. // Annals of Hematology;Aug2015, Vol. 94 Issue 8, p1301 

    In a large proportion of patients with mild bleeding disorders (MBDs) no diagnosis can be established by routine coagulation tests. We investigated whether alterations in plasma clot properties account for MBDs of unknown cause. Ninety-five patients with MBDs of unknown origin and 98 age- and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics